Diageo has announced that the company’s CFO Kathryn Mikells will leave the business later this year and will be replaced by Lavanya Chandrashekar.
The alcohol firm has announced that Kathryn Mikells will return to the US at the end of June after almost six years in the role.
Meanwhile, Lavanya Chandrashekar, the current CFO of Diageo North America and global head of investor relations, will take her place from 1 July.
Mikells joined Diageo from the Xerox Corporation and relocated to London in November 2015. She has since been deemed as instrumental in driving Diageo’s improved performance and in leading a substantial global productivity programme.
As part of her upcoming role, Chandrashekar will join the Diageo executive committee and board. She joined Diageo in her current role in July 2018, where she has since been said to have accelerated growth in Diageo’s North American business and, subsequently, has taken on accountability for investor relations globally.
Prior to joining Diageo, Chandrashekar worked at Mondelēz International for four and a half years and spent 18 years at Procter & Gamble in in various senior finance positions.
Diageo CEO, Ivan Menezes, said: “I am immensely grateful for the leadership role Kathy has played in making Diageo a consistent top-tier performer. She has made a significant contribution to Diageo’s improved performance trajectory, including her leadership of a substantial global productivity programme and her critical role in active management of our brand portfolio through our acquisition and disposal activities.
“I am delighted that Lavanya will take up the role of chief financial officer. She brings a breadth of international experience, has an exceptional grasp of consumer products value creation and world class experience of effective cost management.”
by Emma Upshall
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.